2269.HKRegulatory•prnewswire•August 18, 2025 at 08:00 AM

WuXi Biologics Ireland Facility Receives EMA Approval for Commercial Manufacturing of Innovative Biologic

Sentiment:Positive (80)

Summary

- Further demonstrates WuXi Biologics' Global Dual Sourcing strategy in commercial manufacturing - Underscores the excellence of WuXi Biologics' world-class quality system across its global network DUNDALK, Ireland, Aug. 18, 2025 /PRNewswire/ -- WuXi Biologics (Stock code: 2269.HK), a...

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 18, 2025 by prnewswire